โจ๏ธ Young investigator session 1 on brain targetting and in vitro models. The future of Belgian brain barrier research is looking bright! #BBBelgium24
๐ข Registration is now open for the 3rd Brain Barrier Belgium Symposium on October 14, 2024, in Ghent!
๐ Weโre excited to announce the launch of our new website: bbbelgium.be. Visit to register, check out the event details, and submit your abstracts.
#BBBelgium24
That's a wrap! Our lab represented to connect with a fantastic lineup from periphery to brain at #PBIC24. Thanks to @VIBConferences and all amazing speakers for inspiring sessions and fruitful networking! ๐ค
In our lab, we heavily investigate how we can refine, reduce and replace animal experiments #3Rs. Our team member @laurejmaes presented her work at the #Austrian3RDays about mimicking the small intestine via 3D bioprinting.
Our team represented today at the @ugent_fge research day. @jade_celis is presenting her GAS on fibrostenotic CD, @Febe_Vertriest is showing her study on the effect of mycotoxins on colorectal cancer, and @hannah_lernout is discussing her poster on fatigue in IBD remission.
Very proud of the representation of our IBD UZ Gent team at #BWGE23. Congratulations to everyone for the interesting lectures, posters, and presentations. ๐๐
Congratulations to @hannah_lernout for your intruiging talk at the @birdgroup_be session today at #BWGE23. She presented the results of a study performed together with @marie_truyens in which extinguished chronic colitis was linked to behavioral changes and neuroinflammation.
Great poster from @lmderoo at #BWGE23! She presented her study "Safety of vedolizumab, ustekinumab and TNF-inhibitors in patients with inflammztory bowel disease: a retrospective study". Interesting work!
A very interesting presentation of Tom Holvoet at #BWGE23 today! He presented the results of an ustekinumab effectiveness study in a multi-centric, real-life cohort of highly refractory UC patients. Well done! ๐๐
Congratulations to @GeldofJeroen, who presented the results of the BELCOMID study today at #BWGE23. His research showed that immunomodulating treatment modalities, active smoking, and (repeated) COVID19 vaccination affect S-antibody seroconversion in IMID patients. @birdgroup_be
"A guide within the new JAK world: learning points from experienced EIM colleagues", a fascinating invited lecture by Filip Van Den Bosch at the @birdgroup_be session of #BWGE23. Thank you for the compelling talk!
An eye-opening talk of @FHaerynck at #BWGE23 today. She gave us a clear overview and some intriguing case studies of immune deficiences that mimick IBD. Thank you for the fascinating insights! @birdgroup_be
Congratulations @laurejmaes for winning one of the ECCO Grants of 2023! We could not have wished for a better ending of these insightful last 4 days! Thank you #ECCO2023 organizing committee ๐๐ผ๐๐ผ
Some posters presented by the basic scientists and clinical researchers of the IBD Research Unit UGent/UZ Ghent at #ECCO2023. Well done all! ๐๐ผ๐๐ผ